Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
ACN新闻在线能提供全方位的服务。对于希望向媒体、业界和金融市场披露和传播信息的公司和组织,我们能为您安排实时的新闻发布。ACN新闻在线的新闻稿包括英文、简体中文、繁体中文、韩文和日文等多种语言版本。
Monday, 30 November 2020, 14:00 HKT/SGT
Share:

来源 China Shineway Pharmaceutical Group Limited
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长

香港, 2020年11月30日 - (亚太商讯)  - 神威药业(股份代號:02877.HK)於二零二零年十月份单月营业额比去年同期录得29.4%增长,其中注射液产品、软胶囊产品、颗粒剂产品、中药配方颗粒、及其他剂型产品营业额分别上升了38.9%, 17.4%,38.1%,7.9%,及 54.0% 。

话题 Press release summary

部门 健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network

Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network


Latest Press Releases
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment  
Tuesday, July 8, 2025 8:31:00 AM
Progress towards potassium-ion batteries  
July 8, 2025 06:48 HKT/SGT
Kincora Secures Strategic North American Investors and Announces Private Placement  
July 8, 2025 06:39 HKT/SGT
Small Businesses Embrace Social -- But Could be Missing a Trick in the Age of AI  
July 8, 2025 06:00 HKT/SGT
15 World Toppers and Near-Perfect Scorers for GIIS Singapore in IBDP 2025 Exams  
July 7, 2025 12:00 HKT/SGT
Huatai Foundation Supports NbS Summer School, Convening Global Youth to Tackle Ecological Conservation  
July 7, 2025 10:44 HKT/SGT
MHI Awarded Contract for Basic Design of Japan's Largest CO2 Capture Plant at Hokkaido Electric Power's Tomato-Atsuma Power Station  
Monday, July 7, 2025 10:15:00 AM
Fujitsu's high-precision skeleton recognition AI adopted to enhance figure skating athlete training  
Saturday, July 5, 2025 12:40:00 PM
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation  
July 4, 2025 18:59 HKT/SGT
DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture  
Friday, July 4, 2025 3:20:00 PM
More Press release >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
顶部 | 关于我们 | 服务 | 合作伙伴 | 联系人 | 隐私权政策 | 使用条款 | RSS
美国: +1 214 890 4418 | 中国: +86 181 2376 3721 | 香港: +852 8192 4922 | 新加坡: +65 6549 7068 | 东京: +81 3 6859 8575